{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:18:38Z","timestamp":1792271918665,"version":"4.4.0"},"reference-count":29,"publisher":"American Chemical Society (ACS)","issue":"9","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccby_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Typhoid fever is a major cause of morbidity and mortality in developing countries. Vaccines based on the Vi capsular polysaccharide are licensed or in development against typhoid fever. Vi content is a critical quality attribute for vaccines release, to monitor their stability and to ensure appropriate immune response. Vi polysaccharide is a homopolymer of \u03b1-1,4-N-acetylgalactosaminouronic acid, O-acetylated at the C-3 position, resistant to the commonly used acid hydrolysis for sugar chain depolymerization before monomer quantification. We previously developed a quantification method based on strong alkaline hydrolysis followed by High Performance Anion Exchange Chromatography-Pulsed Amperometric Detection analysis, but with low sensitivity and use for quantification of an unknown product coming from polysaccharide depolymerization. Here we describe the development of a method for Vi polysaccharide quantification based on acid hydrolysis with concomitant use of trifluoroacetic and hydrochloric acids. A Design of Experiment approach was used for the identification of the optimal hydrolysis conditions. The method is 100-fold more sensitive than the previous one, and specifically, resulting in the formation of a known product, confirmed to be the Vi monomer both de-O- and de-N-acetylated by mono- and bidimensional Nuclear Magnetic Resonance spectroscopy and mass spectrometry. Accuracy and precision were determined, and chromatographic conditions were improved to result in reduced time of analysis. This method will facilitate characterization of Vi-based vaccines. Furthermore, a similar approach has the potential to be extended to other polysaccharides containing 2-amino uronic acids, as already verified here for Shigella sonnei O-antigen, Streptococcus pneumoniae serotype 12F, and Staphylococcus aureus types 5 and 8 capsular polysaccharides.<\/jats:p>","DOI":"10.1021\/acs.analchem.9b05107","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T17:40:40Z","timestamp":1587750040000},"page":"6304-6311","source":"Crossref","is-referenced-by-count":32,"title":["Development of a Specific and Sensitive HPAEC-PAD\nMethod for Quantification of Vi Polysaccharide Applicable to other\nPolysaccharides Containing Amino Uronic Acids"],"prefix":"10.1021","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6112-6841","authenticated-orcid":true,"given":"Carlo","family":"Giannelli","sequence":"first","affiliation":[{"name":"GSK Vaccines Institute for Global Health , Via Fiorentina 1 , ,","place":["Siena, Italy, 53100"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6183-965X","authenticated-orcid":true,"given":"Maria Michelina","family":"Raso","sequence":"additional","affiliation":[{"name":"GSK Vaccines Institute for Global Health , Via Fiorentina 1 , ,","place":["Siena, Italy, 53100"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Palmieri","sequence":"additional","affiliation":[{"name":"GSK Vaccines Institute for Global Health , Via Fiorentina 1 , ,","place":["Siena, Italy, 53100"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"De Felice","sequence":"additional","affiliation":[{"name":"GSK Vaccines Institute for Global Health , Via Fiorentina 1 , ,","place":["Siena, Italy, 53100"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pippi","sequence":"additional","affiliation":[{"name":"GSK Vaccines Institute for Global Health , Via Fiorentina 1 , ,","place":["Siena, Italy, 53100"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8243-3181","authenticated-orcid":true,"given":"Francesca","family":"Micoli","sequence":"additional","affiliation":[{"name":"GSK Vaccines Institute for Global Health , Via Fiorentina 1 , ,","place":["Siena, Italy, 53100"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"issue":"4","key":"2026090111532464800_cit1","doi-asserted-by":"publisher","first-page":"e0004616","DOI":"10.1371\/journal.pntd.0004616","article-title":"The Burden\nof Typhoid and Paratyphoid\nin India: Systematic Review and Meta-analysis","volume":"10","author":"John","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"9","key":"2026090111532464800_cit2","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1086\/503033","article-title":"Salmonella\nenterica\nserovar Paratyphi A and S. enterica serovar Typhi cause indistinguishable\nclinical syndromes in Kathmandu, Nepal","volume":"42","author":"Maskey","year":"2006","journal-title":"Clin.\nInfect. Dis."},{"issue":"4","key":"2026090111532464800_cit3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S1473-3099(19)30064-7","article-title":"The global burden of enteric fevers in the age of typhoid-conjugate\nvaccines","volume":"19","author":"Wierzba","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"2026090111532464800_cit4","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1093\/cid\/ciy1111","article-title":"Antibiotic Resistance\nand Typhoid","volume":"68","author":"Dyson","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"2026090111532464800_cit5","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00105-18","article-title":"Emergence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Clone Harboring a Promiscuous\nPlasmid Encoding Resistance to Fluoroquinolones and Third-Generation\nCephalosporins","volume":"9","author":"Klemm","year":"2018","journal-title":"mBio"},{"issue":"5","key":"2026090111532464800_cit6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/infdis\/131.5.553","article-title":"Isolation and characterization of Gal E mutant Ty 21a\nof Salmonella typhi: a candidate strain for a live, oral typhoid vaccine","volume":"131","author":"Germanier","year":"1975","journal-title":"J. Infect. Dis."},{"issue":"6","key":"2026090111532464800_cit7","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.4161\/hv.29054","article-title":"Vaccines against\ninvasive Salmonella\ndisease: current status and future directions","volume":"10","author":"MacLennan","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"issue":"2","key":"2026090111532464800_cit8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines:\nWHO position paper, March 2018 - Recommendations","volume":"37","author":"World Health, O.","year":"2019","journal-title":"Vaccine"},{"issue":"10111","key":"2026090111532464800_cit9","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy\nand immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the\nprevention of typhoid fever using a controlled human infection model\nof Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"2026090111532464800_cit10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi\npolysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy\ninfants, children, and adults in typhoid endemic areas: a multicenter,\n2-cohort, open-label, double-blind, randomized controlled phase 3\nstudy","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"2026090111532464800_cit11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.vaccine.2011.11.108","article-title":"Production\nof a conjugate vaccine for Salmonella enterica serovar Typhi from\nCitrobacter Vi","volume":"30","author":"Micoli","year":"2012","journal-title":"Vaccine"},{"issue":"9","key":"2026090111532464800_cit12","doi-asserted-by":"publisher","first-page":"e25398","DOI":"10.1371\/journal.pone.0025398","article-title":"Safety, immunogenicity\nand dose ranging of a new Vi-CRM(1)(9)(7) conjugate vaccine against\ntyphoid fever: randomized clinical testing in healthy adults","volume":"6","author":"van Damme","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"2026090111532464800_cit13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against\ntyphoid fever in adults, children, and infants in south and southeast\nAsia: results from two randomised, observer-blind, age de-escalation,\nphase 2 trials","volume":"14","author":"Bhutta","year":"2014","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"2026090111532464800_cit15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1006\/biol.1999.0238","article-title":"Use and validation of an NMR test\nfor the identity and O-acetyl content of the Salmonella typhi Vi capsular\npolysaccharide vaccine","volume":"28","author":"Lemercinier","year":"2000","journal-title":"Biologicals"},{"issue":"4","key":"2026090111532464800_cit16","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1128\/JCM.26.4.719-725.1988","article-title":"Application of optical\nproperties of the Vi capsular\npolysaccharide for quantitation of the Vi antigen in vaccines for\ntyphoid fever","volume":"26","author":"Stone","year":"1988","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"2026090111532464800_cit17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0003-2697(92)90349-C","article-title":"Carbohydrate\ncomposition analysis of bacterial polysaccharides: optimized acid\nhydrolysis conditions for HPAEC-PAD analysis","volume":"201","author":"Yu Ip","year":"1992","journal-title":"Anal. Biochem."},{"issue":"19\u201320","key":"2026090111532464800_cit18","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1016\/S0264-410X(02)00183-4","article-title":"Development of a high-performance\nanion-exchange chromatography with pulsed-amperometric detection based\nquantification assay for pneumococcal polysaccharides and conjugates","volume":"20","author":"Talaga","year":"2002","journal-title":"Vaccine"},{"issue":"8","key":"2026090111532464800_cit19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/0264-410X(94)90219-4","article-title":"Quantification\nof polysaccharide\nin Haemophilus influenzae type b conjugate and polysaccharide vaccines\nby high-performance anion-exchange chromatography with pulsed amperometric\ndetection","volume":"12","author":"Tsai","year":"1994","journal-title":"Vaccine"},{"issue":"15\u201316","key":"2026090111532464800_cit20","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0264-410X(00)00427-8","article-title":"Development\nof a new method for the quantitative analysis of the extracellular\npolysaccharide of Neisseria meningitidis serogroup A by use of high-performance\nanion-exchange chromatography with pulsed-amperometric detection","volume":"19","author":"Ricci","year":"2001","journal-title":"Vaccine"},{"key":"2026090111532464800_cit21","doi-asserted-by":"publisher","DOI":"10.1177\/2472630319890309","article-title":"Vaccine\nQuality Ensured by High-Performance Anion-Exchange Chromatography\nwith Pulsed Amperometric Detection","author":"Rohrer","year":"2019","journal-title":"SLAS technology"},{"issue":"4","key":"2026090111532464800_cit22","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.vaccine.2010.11.022","article-title":"Vi-CRM 197 as a new conjugate vaccine against Salmonella\nTyphi","volume":"29","author":"Micoli","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"2026090111532464800_cit23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0021-9258(18)56740-5","article-title":"The reaction\nof acetylcholine and other carboxylic acid derivatives with hydroxylamine,\nand its analytical application","volume":"180","author":"Hestrin","year":"1949","journal-title":"J. Biol. Chem."},{"issue":"8","key":"2026090111532464800_cit24","doi-asserted-by":"publisher","first-page":"e0134478","DOI":"10.1371\/journal.pone.0134478","article-title":"Production of a Shigella sonnei Vaccine\nBased on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB","volume":"10","author":"Gerke","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"2026090111532464800_cit25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1432-1033.1982.tb06634.x","article-title":"A rapid method for acid hydrolysis\nof protein with\na mixture of trifluoroacetic acid and hydrochloric acid","volume":"124","author":"Tsugita","year":"1982","journal-title":"Eur. J. Biochem."},{"issue":"12","key":"2026090111532464800_cit26","doi-asserted-by":"publisher","first-page":"e0189100","DOI":"10.1371\/journal.pone.0189100","article-title":"The influence of conjugation variables on the design\nand immunogenicity of a glycoconjugate vaccine against Salmonella\nTyphi","volume":"12","author":"Arcuri","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"2026090111532464800_cit27","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.carres.2005.02.001","article-title":"Revised structures\nfor the capsular polysaccharides from Staphylococcus aureus Types\n5 and 8, components of novel glycoconjugate vaccines","volume":"340","author":"Jones","year":"2005","journal-title":"Carbohydr. Res."},{"issue":"3","key":"2026090111532464800_cit28","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1128\/CMR.00024-15","article-title":"Pneumococcal Capsules\nand Their Types: Past, Present, and Future","volume":"28","author":"Geno","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"issue":"10100","key":"2026090111532464800_cit29","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"1990\u20132016: a systematic analysis for\nthe Global Burden of Disease Study 2016","volume":"390","author":"Vos","year":"2017","journal-title":"Lancet"},{"issue":"26","key":"2026090111532464800_cit30","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1016\/j.vaccine.2016.02.075","article-title":"Status of vaccine research and development\nfor Shigella","volume":"34","author":"Mani","year":"2016","journal-title":"Vaccine"}],"container-title":["Analytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.analchem.9b05107","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/ancham\/article-pdf\/92\/9\/6304\/67468886\/acs.analchem.9b05107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/ancham\/article-pdf\/92\/9\/6304\/67468886\/acs.analchem.9b05107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:00:26Z","timestamp":1788278426000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/ancham\/article\/92\/9\/6304\/827748\/Development-of-a-Specific-and-Sensitive-HPAEC-PAD"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,4,24]]},"published-print":{"date-parts":[[2020,5,5]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.analchem.9b05107","relation":{},"ISSN":["0003-2700","1520-6882"],"issn-type":[{"value":"0003-2700","type":"print"},{"value":"1520-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]}}}